VERU INC. Foreign Currency Transaction Gain (Loss), before Tax
VERU INC. (VERU) reported Foreign Currency Transaction Gain (Loss), before Tax of -$70.01 thousand for the 3-month period ending 2019-12-31, per its 10-Q filed 2020-02-12.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2020-02-12
- VERU INC. foreign currency transaction gain (loss), before tax for the quarter ending 2019-12-31 was -$70.01K.
- VERU INC. foreign currency transaction gain (loss), before tax for the quarter ending 2019-09-30 was -$15.85K.
- VERU INC. foreign currency transaction gain (loss), before tax for the quarter ending 2019-06-30 was -$16.60K.
- VERU INC. foreign currency transaction gain (loss), before tax for the quarter ending 2019-03-31 was -$23.64K.
- VERU INC. foreign currency transaction gain (loss), before tax for fiscal 2019 was -$73.64K.
- VERU INC. foreign currency transaction gain (loss), before tax for fiscal 2018 was -$126.93K.
- VERU INC. foreign currency transaction gain (loss), before tax for fiscal 2017 was -$61.84K.
- VERU INC. foreign currency transaction gain (loss), before tax for fiscal 2016 was -$147.54K, a 352.28% decline from fiscal 2015.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$70.01K 10-Q · filed 2020-02-12 | -$85.86K derived: sum of 2 quarters · filed 2020-02-12 | -$102.46K derived: sum of 3 quarters · filed 2020-02-12 | -$126.11K derived: sum of 4 quarters · filed 2020-02-12 |
| 2019-09-30 | -$15.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | -$32.45K derived: sum of 2 quarters · filed 2019-12-12 | -$56.10K derived: sum of 3 quarters · filed 2019-12-12 | -$73.64K 10-K · filed 2019-12-12 |
| 2019-06-30 | -$16.60K 10-Q · filed 2019-08-08 | -$40.24K derived: sum of 2 quarters · filed 2019-08-08 | -$57.79K 10-Q · filed 2019-08-08 | -$66.59K derived: sum of 4 quarters · filed 2020-02-12 |
| 2019-03-31 | -$23.64K 10-Q · filed 2019-05-15 | -$41.19K 10-Q · filed 2019-05-15 | -$49.99K derived: sum of 3 quarters · filed 2020-02-12 | -$51.58K derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-12-31 | -$17.54K 10-Q · filed 2020-02-12 | -$26.35K derived: sum of 2 quarters · filed 2020-02-12 | -$27.94K derived: sum of 3 quarters · filed 2020-02-12 | -$91.02K derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | -$8.80K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | -$10.39K derived: sum of 2 quarters · filed 2019-12-12 | -$73.47K derived: sum of 3 quarters · filed 2019-12-12 | -$126.93K 10-K · filed 2019-12-12 |
| 2018-06-30 | -$1.59K 10-Q · filed 2019-08-08 | -$64.67K derived: sum of 2 quarters · filed 2019-08-08 | -$118.12K 10-Q · filed 2019-08-08 | -$139.12K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$63.08K 10-Q · filed 2019-05-15 | -$116.53K 10-Q · filed 2019-05-15 | -$137.53K derived: sum of 3 quarters · filed 2019-05-15 | -$157.67K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$53.45K 10-Q · filed 2019-02-13 | -$74.45K derived: sum of 2 quarters · filed 2019-02-13 | -$94.59K derived: sum of 3 quarters · filed 2019-02-13 | -$103.35K derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-09-30 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | -$41.14K derived: sum of 2 quarters · filed 2018-12-13 | -$49.90K derived: sum of 3 quarters · filed 2018-12-13 | -$61.84K 10-K · filed 2018-12-13 |
| 2017-06-30 | -$20.14K 10-Q · filed 2018-08-14 | -$28.90K derived: sum of 2 quarters · filed 2018-08-14 | -$40.84K 10-Q · filed 2018-08-14 | -$59.94K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$8.76K 10-Q · filed 2018-05-11 | -$20.70K 10-Q · filed 2018-05-11 | -$39.79K derived: sum of 3 quarters · filed 2018-05-11 | -$79.44K derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | -$11.94K 10-Q · filed 2018-02-14 | -$31.04K derived: sum of 2 quarters · filed 2018-02-14 | -$70.69K derived: sum of 3 quarters · filed 2018-02-14 | -$114.54K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | -$19.10K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$58.75K derived: sum of 2 quarters · filed 2018-01-02 | -$102.60K derived: sum of 3 quarters · filed 2018-01-02 | -$147.54K 10-K · filed 2018-01-02 |
| 2016-06-30 | -$39.65K 10-Q · filed 2017-08-09 | -$83.50K derived: sum of 2 quarters · filed 2017-08-09 | -$128.44K 10-Q · filed 2017-08-09 | -$123.24K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-03-31 | -$43.85K 10-Q · filed 2017-05-10 | -$88.79K 10-Q · filed 2017-05-10 | -$83.59K derived: sum of 3 quarters · filed 2018-01-02 | -$79.62K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-12-31 | -$44.94K 10-Q · filed 2017-02-09 | -$39.74K derived: sum of 2 quarters · filed 2018-01-02 | -$35.77K derived: sum of 3 quarters · filed 2018-01-02 | -$7.31K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-09-30 | $5.20K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $9.17K derived: sum of 2 quarters · filed 2018-01-02 | $37.64K derived: sum of 3 quarters · filed 2018-01-02 | $58.48K 10-K · filed 2018-01-02 |
| 2015-06-30 | $3.97K 10-Q · filed 2016-07-28 | $32.43K derived: sum of 2 quarters · filed 2016-07-28 | $53.28K 10-Q · filed 2016-07-28 | $27.65K derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | $28.47K 10-Q · filed 2016-04-28 | $49.31K 10-Q · filed 2016-04-28 | $23.68K derived: sum of 3 quarters · filed 2016-12-12 | $7.86K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $20.85K 10-Q · filed 2016-02-02 | -$4.79K derived: sum of 2 quarters · filed 2016-12-12 | -$20.60K derived: sum of 3 quarters · filed 2016-12-12 | -$44.57K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | -$25.63K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | -$41.45K derived: sum of 2 quarters · filed 2016-12-12 | -$65.42K derived: sum of 3 quarters · filed 2016-12-12 | -$83.84K 10-K · filed 2016-12-12 |
| 2014-06-30 | -$15.82K 10-Q · filed 2015-07-30 | -$39.79K derived: sum of 2 quarters · filed 2015-07-30 | -$58.21K 10-Q · filed 2015-07-30 | -$59.33K derived: sum of 4 quarters · filed 2015-12-02 |
| 2014-03-31 | -$23.97K 10-Q · filed 2015-04-30 | -$42.39K 10-Q · filed 2015-04-30 | -$43.51K derived: sum of 3 quarters · filed 2015-12-02 | -$76.79K derived: sum of 4 quarters · filed 2015-12-02 |
| 2013-12-31 | -$18.43K 10-Q · filed 2015-02-03 | -$19.54K derived: sum of 2 quarters · filed 2015-12-02 | -$52.82K derived: sum of 3 quarters · filed 2015-12-02 | |
| 2013-09-30 | -$1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | -$34.40K derived: sum of 2 quarters · filed 2015-12-02 | -$101.29K 10-K · filed 2015-12-02 | |
| 2013-06-30 | -$33.28K 10-Q · filed 2014-07-31 | -$100.17K 10-Q · filed 2014-07-31 | ||
| 2012-09-30 | -$148.27K 10-K · filed 2014-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |